Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

NCT03520231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma
Kidney Cancer
Ureter Cancer
Bladder Cancer

Interventions

DRUG: Denosumab
OTHER: Denosumab Placebo
DRUG: Gemcitabine
DRUG: Carboplatin
DRUG: Cisplatin
DIETARY_SUPPLEMENT: Calcium
DIETARY_SUPPLEMENT: Vitamin D

Sponsor

University Health Network, Toronto

Collaborators

[object Object]